Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands
There is little evidence on the costs associated with the route of administration of oncology drugs. We investigated time and resource use for hospitals and patients and compared healthcare and societal costs for intravenous (IV) and subcutaneous (SC) administration of trastuzumab and rituximab. Data for the preparation and administration of both drugs were collected at the hospital pharmacy and at the oncology day care unit. Patients completed a questionnaire for obtaining information on societal costs (productivity losses, informal care and traveling expenses). A total of 126 patients were r... Mehr ...
Verfasser: |
Franken, Margreet
Kanters, Tim
Coenen, JL
De Jong, P
Koene, HR
Lugtenburg, Elly
Jager, Agnes
Uyl - de Groot, Carin |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2018 |
Reihe/Periodikum: |
Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648 |
Schlagwörter: |
/dk/atira/pure/keywords/researchprograms/AFL000800/EMCNIHES056302
/ name=EMC NIHES-05-63-02 Quality
/ /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038601
/ name=EMC MM-03-86-01
/ /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038608
/ name=EMC MM-03-86-08 |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-29207344 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/608a1c7a-8ec3-4f24-a024-213e516597de |